Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program - Biogen to test Tysabri as a cancer treatment
Opexa Therapeutics And Myelin Repair Foundation Partner On Novel Multiple Sclerosis Research Program
Medical News Today Fri, 05 Sep 2008 6:17 AM PDT
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc. (MRF).http://www.medicalnewstoday.com/articles/120376.php
Opexa, Myelin Repair partner on sclerosis research programme
PharmaBiz Fri, 05 Sep 2008 3:39 AM PDT
Opexa Therapeutics, Inc, a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, announced the establishment of a novel MS research partnership with the Myelin Repair Foundation, Inc (MRF). As part of this collaboration, Opexa and the MRF will work to identify therapeutically relevant ...
Biogen to test Tysabri as a cancer treatment
Bizjournals.com - Charlotte,NC,USA
Biogen Idec has begun testing the multiple sclerosis drug Tysabri as a treatment for blood cancer. Cambridge, Mass.-based Biogen (Nasdaq: BIIB) and ...
Biogen’s battered MS drug in cancer treatment trials
Mass High Tech - MA, USA
By Mass High Tech Staff Cambridge biotech Biogen Idec and Irish drug partner Elan Corp. began testing their multiple sclerosis drug Tysabri in a phase 2/3 ...
Biogen Idec and Elan Corp Announce Start of Trials with Tysabri as ...
Network Médica - Buenos Aires,Argentina
Elan Corp PLC and Biogen Idec Inc announced the start of Phase I/II trials with Tysabri, their multiple scelerosis and Crohn´s disease drug, with the goal ...
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI® in ...
elEconomista.es - Madrid,Madrid,Spain
The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential ...
Biogen Idec testing Tysabri as a cancer treatment
Boston Globe - United States
Tysabri is already approved for treating multiple sclerosis and Crohn's disease, but there have been setbacks. Tysabri was originally launched in 2004 but ...
Biogen and Elan start testing Tysabri in cancer
Forbes - NY,USA
PLC said they have started the first clinical trial of their multiple sclerosis and Crohn's disease drug Tysabri as a treatment for cancer. ...
Elan, Biogen launch Tysabri trial in oncology
Reuters UK - UK
I: Quote, Profile, Research) have launched the first clinical trial of their multiple sclerosis drug Tysabri for patients with relapsed or refractory ...
Tysabri clinical study underway
Hays Pharma - London,Greater London,UK
Elan Corporation and Biogen Idec have announced that the first clinical trial of Tysabri has begun. The phase-one and phase-two studies seek to assess the ...
Elan, Biogen launch Tysabri trial in oncology
Reuters - USA
I: Quote, Profile, Research, Stock Buzz) have launched the first clinical trial of their multiple sclerosis drug Tysabri for patients with relapsed or ...
Market Report -- In Play (WIRES)
MSN Money - USA
On The Wires Elan (ELN) and Biogen Idec (BIIB) announce the initiation of the first clinical trial of TYSABRI in oncology; the first dose of TYSABRI was ...
I have been diagnosed with MS and I experience a feeling of having bands around my legs. I am a science major and understand the cause of MS but I am curious to what EXACTLY causes these bands.
Banding is a common, but often overlooked MS symptom. It feels like there is something tight around a limb or trunk. The muscles are not actually tight, nor is there any swelling. The sensation of banding is seen in both in MS and spinal cord injury, We therefore assume that the anatomic localization for banding is lesions of the spinal cord. Although the exact physiology is not known, it is likely a form of reduced or altered sensory messaging from the spinal cord to the area of the brain that perceives sensation. Something similar would be the way your face feel ”fat” when you have dental freezing.
9/5/2008 10:05:52 PM
DISCLAIMER: Please be aware that this information does not necessarily represent the opinion of the MS Society of Canada, and is not intended as medical advice. For specific advice and opinion, always consult a physician.
© 2008 Multiple Sclerosis Society of Canada | www.mssociety.c
Update on Relapsing-Remitting MS: B-cell Depletion with Rituximab
IIn this article review, Dr. Bruce Cree comments on a recent clinical trial that explored the use of rituximab, a monoclonal antibody directed against CD20+ B lymphocytes, as therapy for patients with multiple sclerosis.
Source: Projects In Knowledge
o As of the end of August, we had enrolled 1294 subjects into our
o We distributed data from our repository database to Alan Ruttenberg
of ScienceCommons, who is developing methods for structuring and
analyzing data and would like to apply these methods to better
o We received one new proposal for use of repository samples and data
and are currently reviewing it.
o Sara, Art and Hollie had a phone call with Phil DeJager and Ben
Greenberg about potential future collaborations.
o Hollie talked with Silke Schmidt from Duke University to get her
advice about using our repository for gene/environment studies.
o Hollie and Art spoke with Nancy Barrand and Theresa Dixon of the
Robert Wood Johnson Foundation, who wanted to know more about the
Other Science Efforts:
o A newly updated version of our MS genetic studies database has been
posted and can be found here:
o Hollie and Art had lunch with scientific advisor Maria Lopez-Bresnahan
to learn about her new job at i3 Research.
o Poll - What is your natural hair color?
o We continue our daily MS News updates
o Nothing new to report
>>> Community Building
o As always, a few more T-shirt pictures are available:
>>> Upcoming Events
Detailed information about all of our upcoming events can be found on
our web site:
Statin Therapy Underused in Elderly Patients With Atherosclerosis
CHICAGO -- August 28, 2008 -- Use of statin therapy to combat the adverse cardiovascular outcomes from atherosclerosis is underused is elders, according to new research published in the September 2008 issue of the Journal of Vascular Surgery. In a 10-year population-based study (1995-2005) of 343,154 elderly patients in Ontario, ...Full Story
Treadmill Exercise Retrains Brain and Body of Stroke Victims, Even Years After Stroke